Literature DB >> 26401090

Co-occurrence of carbohydrate malabsorption and primary epiploic appendagitis.

Wolfgang J Schnedl1, Peter Kalmar1, Harald Mangge1, Robert Krause1, Sandra J Wallner-Liebmann1.   

Abstract

Unspecific abdominal complaints including bloating and irregular bowel movements may be caused by carbohydrate malabsorption syndromes, e.g., lactose and fructose malabsorption. These symptoms were investigated with hydrogen (H2) breath tests and correlated to carbohydrate malabsorption. During performing these H2-breath tests the patient presented with an acute, localized, non-migratory pain in the left lower abdominal quadrant. Primary epiploic appendagitis is a rare cause of abdominal acute or subacute complaints and diagnosis of primary epiploic appendagitis (PEA) is made when computed tomography reveals a characteristic lesion. We report on a patient with co-occurrence of lactose and fructose malabsorption, which was treated successfully with a diet free of culprit carbohydrates, with PEA recovering without medication or surgical treatment within few days. Since the abdominal unspecific symptoms had been present for months, they appeared not to be correlated to the acute localized abdominal pain, therefore we speculate on a random co-occurrence of combined carbohydrate malabsorption and PEA.

Entities:  

Keywords:  Carbohydrate malabsorption; Computed tomography; Fructose malabsorption; Lactose malabsorption; Primary epiploic appendagitis

Mesh:

Substances:

Year:  2015        PMID: 26401090      PMCID: PMC4572806          DOI: 10.3748/wjg.v21.i35.10242

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  [Primary epiploic appendagitis: clinical features in 73 cases].

Authors:  Graciela M Vázquez; Matías E Manzotti; Graciana Alessandrini; Sofía Lemos; María Clara Perret; Hugo N Catalano
Journal:  Medicina (B Aires)       Date:  2014       Impact factor: 0.653

2.  CT appearance of acute appendagitis.

Authors:  Ajay K Singh; Debra A Gervais; Peter F Hahn; James Rhea; Peter R Mueller
Journal:  AJR Am J Roentgenol       Date:  2004-11       Impact factor: 3.959

Review 3.  Insights into epiploic appendagitis.

Authors:  Wolfgang J Schnedl; Robert Krause; Erwin Tafeit; Manfred Tillich; Rainer W Lipp; Sandra J Wallner-Liebmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-23       Impact factor: 46.802

4.  Primary epiploic appendagitis and fructose malabsorption.

Authors:  W J Schnedl; R W Lipp; S J Wallner-Liebmann; P Kalmar; D H Szolar; H Mangge
Journal:  Eur J Clin Nutr       Date:  2014-06-18       Impact factor: 4.016

Review 5.  Carbohydrate malabsorption in patients with non-specific abdominal complaints.

Authors:  Peter Born
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

6.  Differential diagnosis of left-sided abdominal pain: primary epiploic appendagitis vs colonic diverticulitis.

Authors:  Jeong Ah Hwang; Sun Moon Kim; Hyun Jung Song; Yu Mi Lee; Kyung Min Moon; Chang Gi Moon; Hoon Sup Koo; Kyung Ho Song; Yong Seok Kim; Tae Hee Lee; Kyu Chan Huh; Young Woo Choi; Young Woo Kang; Woo Suk Chung
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 7.  Torsion of the primary epiploic appendagitis: a case series and review of the literature.

Authors:  Suleyman Ozdemir; Kamil Gulpinar; Sezai Leventoglu; Hatim Yahya Uslu; Erdem Turkoz; Necdet Ozcay; Atila Korkmaz
Journal:  Am J Surg       Date:  2009-06-11       Impact factor: 2.565

8.  Primary epiploic appendagitis and successful outpatient management.

Authors:  Wolfgang J Schnedl; Robert Krause; Sandra J Wallner-Liebmann; Erwin Tafeit; Harald Mangge; Manfred Tillich
Journal:  Med Sci Monit       Date:  2012-06

9.  Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption.

Authors:  Miriam Goebel-Stengel; Andreas Stengel; Marco Schmidtmann; Ivo van der Voort; Peter Kobelt; Hubert Mönnikes
Journal:  J Neurogastroenterol Motil       Date:  2014-04-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.